Wikidata

(Q63317381)

English

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

clinical trial

In more languages

Statements

title
Phase I, Randomized, Controlled, Observer-Blind, Dose-Ranging Study of Acellular Pertussis and Tetanus-Diptheria-Acellular Pertussis Booster Vaccine in Adults Ages 18 to 40 Years. (English)
0 references
medical condition
tetanus
0 references
tetany
0 references
diphtheria
0 references
sponsor
Novartis
0 references
country
Belgium
0 references
start time
March 2012
0 references
end time
July 2012
0 references
number of participants
420
0 references
minimum age
18 year
0 references
maximum age
40 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63317381&oldid=2149204897"